The breast-stimulated contraction stress test.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Reproductive Physiology

Background:

• The contraction stress test (CST) is a common method for assessing fetal well-being.
• Traditionally, the oxytocin challenge test (OCT) is used, requiring intravenous oxytocin infusion.
• Alternative methods for inducing uterine contractions are sought to improve patient comfort and reduce procedural complexity.

Purpose of the Study:

• To evaluate the efficacy and safety of a novel method using breast stimulation to induce uterine contractions for a contraction stress test (BSCST).
• To compare the results and efficiency of BSCST with the traditional OCT.

Main Methods:

• A prospective study involving 657 patients undergoing BSCST.
• Breast stimulation was used to elicit uterine contractions.
• Test results (positive, negative, equivocal) and time to adequate uterine response were recorded.
• Comparison of BSCST outcomes with historical OCT data.

Main Results:

• BSCST achieved a 72.2% success rate in inducing uterine contractions across 1,484 attempts.
• Success rates were lower in gestations ≤ 34 weeks.
• Test result distributions (positive, negative, equivocal) were comparable to OCT.
• The mean time for adequate uterine response was 23.8 minutes, with 87.5% responding within 30 minutes.
• Corrected perinatal mortality rate was 1.5 per 1,000 births.

Conclusions:

• Breast stimulation contraction stress test (BSCST) is a safe and effective alternative to OCT.
• BSCST eliminates the need for IV lines and oxytocin, potentially reducing patient discomfort and procedural time.
• The method demonstrates comparable diagnostic accuracy to OCT with improved efficiency.